Another study by J. Tschui revealed that approximately three-quarters of aggressive HER2 gene-amplified subtypes of bladder cancer showed HER2 protein overexpression (Tschui et al., 2015). This evidence concerns the gene ERBB2 and urinary bladder carcinoma.